“The Buzz” Show: Radius Health, Inc. (NASDAQ: RDUS) & Menarini Group Announce EMERALD Study Results | Financial Buzz

“The Buzz” Show: Radius Health, Inc. (NASDAQ: RDUS) & Menarini Group Announce EMERALD Study Results

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Radius Health, Inc. and Menarini Group Announce Positive Phase 3 Topline Results from the EMERALD Study

Radius Health, Inc. (NASDAQ: RDUS) surged over 37% in premarket trading after the company and the Menarini Group announced positive topline results from the EMERALD study.

The study was designed to evaluate elacestrant as a monotherapy versus the current standard of care and EMERALD met both primary endpoints, showing statistically significant PFS in the overall population and ESR1 mutation subgroup. 

For more information, please visit: Radius Health, Inc.

About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!